Thanks @Kryptonite
Good to see Acadia progress ROW opportunities ... aiming for Canada by end 2024
I think this slide is also important:
Note NNZ-2591 is back in their slide pack as ACP-2591 for Rett Syndrome and Fragile X .... pink bar above
Footnote: "3 The safety and efficacy of these investigational agents have not been established. There is no guarantee these investigational agents will be filed with or approved by any regulatory agency.
Thanks @KryptoniteGood to see Acadia progress ROW opportunities...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.20 |
Change
-0.050(0.26%) |
Mkt cap ! $2.451B | |||
| Open | High | Low | Value | Volume |
| $19.16 | $19.44 | $19.06 | $4.162M | 216.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3727 | $19.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.27 | 399 | 1 |
View Market Depth
| Last trade - 16.10pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.26 |
Change
-0.050 ( 0.17 %) |
||||
| Open | High | Low | Volume | ||
| $19.22 | $19.43 | $19.05 | 52522 | ||
| Last updated 15.59pm 30/04/2024 ? | |||||
| NEU (ASX) Chart |